Latest Financial Health News

Aeris Resources has delivered a standout FY25 performance, posting a 78% rise in EBITDA and a 286% surge in net profit, driven by strong commodity prices and disciplined cost management.

The Agency Group has delivered a record financial performance in FY2025, with Gross Commission Income surpassing $125 million, driven by strong growth in residential sales and property management. The company’s unique national direct agency model and strategic expansion into emerging markets underpin its positive outlook.

FOS Capital Limited reported a solid 47.5% jump in net profit for the 2025 financial year alongside a modest revenue increase, announcing a final dividend of 1 cent per share.

Activeport Group Ltd reported a significant $15.7 million net loss for FY25, driven by a $10.9 million goodwill impairment, as it pivots towards recurring software revenue. The company plans a $2.5 million rights issue to support this transition amid ongoing financial challenges.

Pureprofile Ltd has reported a remarkable turnaround with a 19% revenue increase and a 1531% jump in profit after tax for the year ended June 2025, signaling renewed momentum in the data analytics sector.

Solvar Limited reported a notable 84.4% jump in net profit for FY25 even as revenue declined 6.1%, alongside a healthy dividend increase.

Anagenics Limited has revealed a significant 52.6% decline in revenue alongside an 83.5% increase in net loss for the financial year ended June 2025, marking a challenging period for the biotech company.

Farm Pride Foods Ltd has reported a remarkable 384% increase in net profit for the financial year ending June 2025, despite revenues remaining virtually unchanged. The company’s financial health shows signs of strengthening, though no dividends were declared.

De.mem Limited reported a 19.7% increase in revenue to $13.96 million for the half-year ended June 2025, alongside a 42% reduction in net loss and its first positive adjusted EBITDA in years. Strategic acquisitions and expansion into Asian domestic markets underpin the company’s improving financial health.

Comms Group delivered FY25 results at the upper end of guidance, boosted by record new sales and the acquisition of TasmaNet. The company sets sights on accelerated growth and integration benefits in FY26.

Starpharma has received a $3.7 million R&D Tax Incentive refund for the 2025 financial year, reinforcing its commitment to advancing dendrimer technology and biotechnology innovation in Australia.

PointsBet Holdings Limited has issued a supplementary statement urging shareholders to reject betr Entertainment’s increased scrip offer, reaffirming support for MIXI Australia’s competing cash bid. The board highlights risks tied to betr’s offer and underscores the superior value of the MIXI proposal.